Hemophilia Stories
Will getting a blood transfusion change your DNA? Yes and no.
Biogen Inc said on Tuesday it would spin off its hemophilia drug business as a publicly traded company in a tax-free transaction, leaving the drugmaker to focus on developing drugs for neurodegenerative diseases.
Despite positive medical progress, many men living with hemophilia face treatment disparities and frequent bleeding.
Baxalta Inc's drug, Adynovate, has been approved to control and reduce the frequency of bleeding episodes in patients with Hemophilia A, the agency said in a statement on Friday.
A new virus has been found to be transmitted through blood transfusions, but it doesn't seem dangerous.
Roche's experimental hemophilia drug will be fast-tracked after the Food and Drug Administration granted it breakthrough therapy status.- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients.
- Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia (WFH) 2010 Congress.